ArticleJournal of toxicology2026
In Vivo Acute and Subchronic Toxicity of
Article in Journal of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite its traditional use in Africa for weight management, the safety profile of the aqueous stem bark extract of Methods: Acute toxicity was assessed according to OECD Guideline 425 using a single oral dose of 5000 mg/kg. Subchronic toxicity was evaluated over 56 days at doses of 150, 300 and 600 mg/kg/day. Satellite groups (the control and the 600 mg/kg/day group) were maintained for an additional 14 days to observe the reversibility of any treatment-related effects. Parameters studied included body/organ weights, haematological, biochemical, lipid and histopathological profiles. Results: No mortalities or signs of acute toxicity were observed during the 14 days following extract administration. Subchronic administration did not affect survival or relative organ weights, although the 600 mg/kg dose induced minor structural alterations in affected organs. The extract significantly reduced body weight gain. At 150 mg/kg, the extract sex-specifically improved lipid profiles by lowering triglycerides in males and increasing HDL cholesterol in females. Haematological assessment revealed a dose-dependent increase in platelet counts in male rats at 600 mg/kg, which returned to baseline levels after the 14-day recovery period. Elevated AST and ALT fully reversed in females post-recovery; however, elevated ALT persisted at 600 mg/kg in males. Creatinine remained stable or decreased, and minor variations in urea concentrations in both sexes returned to baseline during recovery. Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.